main content start
¿Le gustó este contenido?
Cancer de prostata 7m 6s

Treating Metastatic Hormone Refractory Prostate Cancer - My Approach

Publicado11 Jul 2022
Revised definition of Castration Resistant Prostate Cancer (mCRPC) considers castration range testosterone with either biochemical progression with three consecutive rises in PSA or evidence of radiological progression. There are three paradigms of treatment of prostate Cancer : Progression post ADT , Progression post upfront Docetaxel , Progression post upfront Androgen Receptor Targeted Agents (ARTA). Switching from one treatment to another is recommended if any two of the three criterions are met: PSA progression , radiological progression , symptomatic progression.
castration resistance mcrpc metastatic prostate cancer prostate cancer

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Ventajas de registrarse en MedEnrich
Contenido en línea en varios formatos
Contenido personalizado
Acceso ilimitado a todas las funciones
Hi, can I help?
Chat de ayudaX
Equipo de soporte
¡Hola! ¿Cómo puedo ayudarlo/a hoy?
Por favor seleccione alguna de las siguientes opciones.

Buscar información

Problemas con el inicio de sesión o registro

Compartir un comentario